Clinical Trial Update: Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease [EARLY_Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for ceftriaxone pulse dosing to treat Post-Treatment Lyme Disease, currently recruiting at SUNY Upstate Medical Universi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-treatment Lyme Disease

Drugs mentioned

• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Post-Treatment Lyme Disease | EARLY_Phase 1 | Status: RECRUITING